# Business Recommendations

## Executive Summary
The project demonstrates a complete healthcare analytics and machine-learning workflow. Its strongest finding is a governance finding: the synthetic data supports engineering practice but not clinically meaningful prediction.

## Recommendations
1. Enforce schema, uniqueness, date consistency, billing ranges, and reference-data checks.
2. Retain negative billing records with an adjustment/reversal flag and exclude them from gross revenue until validated.
3. Generate surrogate admission IDs rather than relying on names or room numbers.
4. Do not operationalize the classifier.
5. Acquire governed real-world data with a defined, time-bounded outcome.
6. Require temporal validation, calibration, subgroup performance, and human review.

## Risk Assessment
- Clinical risk: high if predictions are treated as advice
- Data provenance risk: high because records are synthetic
- Model risk: high because discrimination is near chance
- Operational risk: moderate if quality exceptions enter dashboards unflagged
- Privacy risk: low for the synthetic file; real use would require HIPAA-aligned controls

## Future Opportunities
Billing anomaly detection, length-of-stay modeling, readmission risk with longitudinal data, bed-demand forecasting, and fairness/calibration dashboards after valid data governance is established.
